6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine, 98%, 100mg

(3-aminopropyl)(6-methyl-2-propyl-4-pyrimidinyl)amine, 95.0%, 5g

7-Bromo-1H-pyrido[3,4-b][1,4]oxazin-2-one, 95+%, 250mg

2-Bromo-5-iodo-p-xylene, 97.0%, 25g

1-(2,6-Diisopropylphenyl)-1H-imidazole, 98%, 1g

(R)-2-Aminohexan-1-ol hydrochloride, 97%, 10g

Benzyl 3-Aminoazetidine-1-carboxylate, 97.0%, 100g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

Nipecotamide>98.0%(T)5g

(2S,4R)-4-((Benzyloxy)methyl)-5-oxopyrrolidine-2-carboxylic acid, 100mg

5,6-Dimethylbenzo[d]thiazol-2-amine, 95.0%, 5g

Sodium (2-chloro-6-fluorophenyl)methanesulfinate, 95+%, 250mg

N,N'-Di (p-tolyl)-2-thiourea, 99.0%, 100g